AstraZeneca PLCAZNNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank36
3Y CAGR-54.7%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-54.7%/yr
vs +38.6%/yr prior
Acceleration
-93.3pp
Decelerating
Percentile
P36
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 1.42% |
| 2024 | 10.99% |
| 2023 | 1.32% |
| 2022 | 15.36% |
| 2021 | 31.05% |
| 2020 | -0.74% |
| 2019 | 9.13% |
| 2018 | 4.16% |
| 2017 | 8.26% |
| 2016 | -15.43% |